Digestive Diseases Center, Showa University Koto-Toyosu Hospital, Toyosu 5-1-38, Koto-Ku, Tokyo, 135-8577, Japan.
Department of Gastroenterological Surgery, Fukuoka University Faculty of Medicine, 7-45-1, Nanakuma, Jyonan-ku, Fukuoka, 814-0180, Japan.
Esophagus. 2020 Jan;17(1):3-10. doi: 10.1007/s10388-019-00689-6. Epub 2019 Sep 26.
It has been 10 years since peroral endoscopic myotomy (POEM) was reported for the first time, and POEM has currently become the standard treatment for achalasia and related disorders globally because it is less invasive and has a higher curative effect than conventional therapeutic methods. However, there are limited studies comparing the long-term outcomes of POEM with those of conventional therapeutic methods, particularly in the occurrence of gastroesophageal reflux disease (GERD) after therapy. With this background, we held a consensus meeting to discuss the pathophysiology and management of GERD after POEM based on published papers and experiences of each expert and to discuss the prevention of GERD and dealing with anti-acid drug refractory GERD. This meeting was held on April 27, 2018 in Tokyo to establish statements and finalize the recommendations using the modified Delphi method. This manuscript presents eight statements regarding GERD after POEM.
经口内镜下肌切开术(POEM)问世至今已有 10 年,目前 POEM 已成为全球治疗贲门失弛缓症及相关疾病的标准治疗方法,因其具有创伤小、疗效高的优点,优于传统的治疗方法。然而,目前比较 POEM 与传统治疗方法长期疗效的研究较少,特别是在治疗后胃食管反流病(GERD)的发生情况方面。有鉴于此,我们召开了一次共识会议,根据已发表的论文和每位专家的经验,讨论 POEM 后 GERD 的病理生理学和管理,并探讨 GERD 的预防以及处理抗酸药物难治性 GERD。此次会议于 2018 年 4 月 27 日在东京举行,采用改良 Delphi 法达成共识并最终确定推荐意见。本文提出了 8 条关于 POEM 后 GERD 的声明。